(Q54292759)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

L K Vigsnæs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

J Brynskov

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

C Steenholdt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Wilcks

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

287-297

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

Mucosa-associated bacterial diversity in relation to human terminal ileum and colonic biopsy samples

13 February 2020

cites work

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Mesalazine (5-aminosalicylic acid) alters faecal bacterial profiles, but not mucosal proteolytic activity in diarrhoea-predominant irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Enterotypes of the human gut microbiome

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Induction of colonic regulatory T cells by indigenous Clostridium species

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Comparison of methods and animal models commonly used for investigation of fecal microbiota: effects of time, host and gender.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Bacteria as the cause of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Development of a real-time PCR assay for monitoring anaerobic fungal and cellulolytic bacterial populations within the rumen.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Identification and quantitation of mucosal and faecal desulfovibrios using real time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

From the gut to the peripheral tissues: the multiple effects of butyrate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Molecular diversity of Lactobacillus spp. and other lactic acid bacteria in the human intestine as determined by specific amplification of 16S ribosomal DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Quantification of bacteria adherent to gastrointestinal mucosa by real-time PCR.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Role of probiotic therapy in IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Effects of mesalamine (5-aminosalicylic acid) on bacterial gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Changes in bacterial community structure in the colon of pigs fed different experimental diets and after infection with Brachyspira hyodysenteriae

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Rapid identification of the species of the Bacteroides fragilis group by multiplex PCR assays using group- and species-specific primers

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

In vitro alterations of intestinal bacterial microbiota in fecal samples during storage.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Lactobacillus fermentum, a probiotic capable to release glutathione, prevents colonic inflammation in the TNBS model of rat colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Thickness of adherent mucus gel on colonic mucosa in humans and its relevance to colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

A human gut microbial gene catalogue established by metagenomic sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Anti-inflammatory effects of bifidobacteria by inhibition of LPS-induced NF-kappaB activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Therapeutic correction of bacterial dysbiosis discovered by molecular techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Quantitative PCR for detection and enumeration of genetic markers of bovine fecal pollution

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Molecular profiling of the Clostridium leptum subgroup in human fecal microflora by PCR-denaturing gradient gel electrophoresis and clone library analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Low counts of Faecalibacterium prausnitzii in colitis microbiota.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Azathioprine and mesalazine-induced effects on the mucosal flora in patients with IBD colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

The genome of Akkermansia muciniphila, a dedicated intestinal mucin degrader, and its use in exploring intestinal metagenomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Detection and identification of gastrointestinal Lactobacillus species by using denaturing gradient gel electrophoresis and species-specific PCR primers

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Molecular characterisation of the faecal microbiota in patients with type II diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Lactobacillus acidophilus induces a slow but more sustained chemokine and cytokine response in naïve foetal enterocytes compared to commensal Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

Potential probiotic lactic acid bacteria Lactobacillus rhamnosus (HN001), Lactobacillus acidophilus (HN017) and Bifidobacterium lactis (HN019) do not degrade gastric mucin in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

A microbial world within us

21 January 2018

1 reference

https://api.crossref.org/works/10.3920%2FBM2012.0018

21 January 2018

Identifiers

DOI

10.3920/BM2012.0018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22968374%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference